Apr 13, 2024
Xencor is a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of patients with cancer and other serious diseases.
Xencor
seen from United States
seen from Poland
seen from Hong Kong SAR China
seen from United States
seen from United Kingdom
seen from Malaysia
seen from United States
seen from United States
seen from United States
seen from China
seen from United States
seen from Norway
seen from Austria
seen from Norway
seen from United States
seen from Türkiye
seen from Türkiye
seen from Singapore
seen from Norway
seen from Vietnam
Xencor is a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of patients with cancer and other serious diseases.
Xencor
The plug-and-play nature of Xencor’s XmAb technology enables the rapid creation of more powerful, more effective antibodies by simply changing a few amino